Game Creek Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Game Creek Capital's REGN Position: Q1 2026 in Review
Game Creek Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 34% in Q1 2026, selling an estimated $2.23M and leaving 5,525 shares worth $4.27M. The position accounts for 1.42% of the portfolio, ranked #26.
Game Creek Capital first reported a position in REGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.51M in Q4 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Game Creek Capital held 5,525 shares of Regeneron Pharmaceuticals worth $4.27M as of Q1 2026.
- Game Creek Capital sold 2,910 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.23M.
- Regeneron Pharmaceuticals made up 1.42% of Game Creek Capital's portfolio in Q1 2026, its #26 holding.
- Game Creek Capital first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- Game Creek Capital's Regeneron Pharmaceuticals position peaked at $6.51M in Q4 2025.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.